opiate

Studies associated with:
Division Study Number Title Investigator(s) Release Date
CTN NIDA-CTN-0055 Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (CHOICES) P. Todd Korthuis, MD
CTN NIDA-CTN-0051A2 Treatment-as-Usual Opioid Use Outcomes Following Discharge from Detoxification and Short-Term Residential Programs Affiliated with NIDA CTN-0051 John Rotrosen, M.D.
CTN NIDA-CTN-0067 Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up P. Todd Korthuis, MD
CTN NIDA-CTN-0093 Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool Gerald Cochran, PhD, T. John Winhusen, Ph.D.
CTN NIDA-CTN-0075 Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder Li-Tzy Wu, Psy.D., Paolo Mannelli, MD
CTN NIDA-CTN-0051 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment John Rotrosen, M.D.
DTMC NIDA-CSP-1020 A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal Ann Montgomery, R.N.
CTN NIDA-CTN-0059 The TAPS Tool: Screen and Brief Assessment Tool Validation Study Robert P Schwartz, M.D., Li-Tzy Wu, Psy.D., Jennifer McNeely, M.D.
CTN NIDA-CTN-0030A3 Long-Term Follow-Up to CTN-0030 (A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence) Roger Weiss, M.D., Jennifer Sharpe Potter, Ph.D.
CTN NIDA-CTN-0030 A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence Walter Ling, M.D., Roger Weiss, M.D.
CTN NIDA-CTN-0027 Starting Treatment with Agonist Replacement Therapies (START) Walter Ling, M.D.
CTN NIDA-CTN-0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules Walter Ling, M.D.
CTN NIDA-CTN-0002 Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification Walter Ling, M.D.
CTN NIDA-CTN-0001 Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification Walter Ling, M.D.
DTMC NIDA-CSP-1018 A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence Walter Ling, M.D., Paul J. Fudala, Ph.D., Paul Casadonte, M.D.
DTMC NIDA-CSP-1008B A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence Peter Bridge, M.D.
DTMC NIDA-CSP-1008A A Multicenter Efficacy/Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence Peter Bridge, M.D., Paul J. Fudala, Ph.D.
DTMC NIDA-CSP-999 A Multicenter Clinical Trial of Buprenorphine in Treatment of Opiate Dependence Walter Ling, M.D., Donald R. Wesson, M.D., C. James Klett, Ph.D.